RhumbLine Advisers’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

RhumbLine Advisers’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,007	Closed	-$19.2K	–	4299
2023 Q4	$19.2K	Sell	16,007 -2,310	-13%	-$2.49K	﹤0.01%	3776
2023 Q3	$15.8K	Buy	18,317 +2,857	+18%	+$3.13K	﹤0.01%	3813
2023 Q2	$18.6K	Buy	+15,460	New	+$77.3K	﹤0.01%	3825
2022 Q2	–	Sell	-11,319	Closed	-$57K	–	3284
2022 Q1	$57K	Buy	11,319 +725	+7%	+$5.81K	﹤0.01%	2965
2021 Q4	$136K	Buy	+10,594	New	+$151K	﹤0.01%	2904

RhumbLine Advisers's RAIN Position: Q1 2024 in Review

RhumbLine Advisers sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 16,007 shares — an estimated $19.2K sold.

RhumbLine Advisers first reported a position in RAIN in Q4 2021 and held it in 5 quarters. The position peaked at $136K in Q4 2021. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

RhumbLine Advisers reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
RhumbLine Advisers sold 16,007 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $19.2K.
RhumbLine Advisers first reported a position in Rain Oncology Inc. Common Stock in Q4 2021 and held it in 5 quarters.
RhumbLine Advisers's Rain Oncology Inc. Common Stock position peaked at $136K in Q4 2021.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.